Literature DB >> 3549724

Purification and properties of an endothelial cell growth factor from human platelets.

K Miyazono, T Okabe, A Urabe, F Takaku, C H Heldin.   

Abstract

An endothelial cell growth factor has been purified about 1,000,000-fold to homogeneity from human platelets by a seven-step procedure. The purified product has an apparent Mr on sodium dodecyl sulfate-polyacrylamide gels of 45,000. The mobility in sodium dodecyl sulfate gel electrophoresis was similar in the presence or absence of reducing agents, indicating that the factor consists of a single polypeptide chain. Maximal stimulation by the purified protein was achieved at a concentration of about 20 ng/ml (440 pM). Heparin did not potentiate the activity, nor did the factor bind to heparin immobilized on Sepharose. The purified factor was heat- and acid-labile; it was active on porcine and human endothelial cells, but not on human foreskin fibroblasts. Chromatofocusing revealed that the pI of the factor was 4.6. The structural and functional characteristics of the platelet-derived endothelial cell growth factor are distinct from previously characterized endothelial cell mitogens with affinities for heparin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling.

Authors:  Virginie S Vervoort; Séverine Roselli; Robert G Oshima; Elena B Pasquale
Journal:  Gene       Date:  2007-01-08       Impact factor: 3.688

4.  Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form.

Authors:  K Usuki; L Norberg; E Larsson; K Miyazono; U Hellman; C Wernstedt; K Rubin; C H Heldin
Journal:  Cell Regul       Date:  1990-07

5.  Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase.

Authors:  G J Barton; C P Ponting; G Spraggon; C Finnis; D Sleep
Journal:  Protein Sci       Date:  1992-05       Impact factor: 6.725

6.  Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line.

Authors:  G Conn; D D Soderman; M T Schaeffer; M Wile; V B Hatcher; K A Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Transition state analysis of the arsenolytic depyrimidination of thymidine by human thymidine phosphorylase.

Authors:  Phillip A Schwartz; Mathew J Vetticatt; Vern L Schramm
Journal:  Biochemistry       Date:  2011-02-03       Impact factor: 3.162

8.  B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase.

Authors:  B Westermark; A Siegbahn; C H Heldin; L Claesson-Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

9.  Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling.

Authors:  Sho-ichi Yamagishi; Riichiro Abe; Yosuke Inagaki; Kazuo Nakamura; Hiroshi Sugawara; Daisuke Inokuma; Hideki Nakamura; Tadamichi Shimizu; Masayoshi Takeuchi; Akihiko Yoshimura; Richard Bucala; Hiroshi Shimizu; Tsutomu Imaizumi
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

10.  Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform.

Authors:  Soochong Kim; Analia Garcia; Shaun P Jackson; Satya P Kunapuli
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.